EMT-6 murine mammary tumors were made resistant to cis -diamminedichloroplatinum (II) (CDDP), carboplatin, cyclophosphamide (CTX), or thiotepa in vivo by treatment of tumor-bearing animals with the drug during a 6-month period. In spite of high levels of in vivo resistance, no significant resistance...
No comments yet
Be the first to share your thoughts!